People wait outside a COVID-19 vaccine distribution center at the Kedren Community Health Center on January 28, 2021 in Los Angeles, California.
Mario Tama | Getty Images
The White House will begin delivering doses of Covid-19 vaccines directly to state-qualified community health centers next week in an effort to extend reach to traditionally underserved communities, Jeff Zients, White House Response Coordinator for Covid-19, announced Tuesday .
Along with other initiatives such as government-sponsored mass vaccination centers and mobile clinics, the new program aims to ensure fair adoption of the vaccine, said Zients.
“Justice is at the core of our strategy to move out of this pandemic, and justice means reaching out to everyone, especially those in underserved and rural communities,” Zients said. “But we cannot do this effectively at the federal level without our partners at the state and local levels sharing the same commitment to justice.”
Dr. Marcella Nunez-Smith, Chair of the White House’s Covid-19 Health Equity Task Force, noted that there are more than 1,300 community health centers across the country serving nearly 30 million people.
“Two-thirds of their patients live at or below the federal poverty line, and 60% of patients in community health centers identify as racial or ethnic minorities,” she noted. “Justice is our north star here. These efforts, which focus on direct referral to community health centers, are really about connecting with hard-to-reach populations across the country.”
When the program launches, the White House plans to send cans to at least one center in each state, with 1 million split between 250 centers over the coming weeks, Nunez-Smith said. She noted that the government is also working to increase public confidence in vaccines, “which we know are lower than the national average in underserved communities”.
The community health center program will be announced after the launch of the retail pharmacy program, where the federal government will begin shipping cans directly to a few hundred pharmacies across the country. Nunez-Smith said the Centers for Disease Control and Prevention are working with participating pharmacy companies to ensure they reach “socially vulnerable areas”.
The government also announced that it will again increase the number of doses it sends to states each week. The federal government will now ship 11 million cans to states every week, up from the 8.6 million it sent three weeks ago, Zients said.
“That’s a 28% increase in vaccine delivery in the first three weeks,” he said.
When asked whether there is an inevitable trade-off between equity and speed of vaccine distribution, Zients said, “I do not accept that premise at all.”
“I think we can do this in a fair, equitable and efficient way,” he said. “Efficiency and equity are central to both of us and I don’t see any compromise between the two. I think they go hand in hand.”
Confidence in the vaccine has increased among adult Americans, but some populations have shown greater levels of reluctance to use the drugs toward others, according to a new CDC released Tuesday. Almost half of the adult Americans surveyed in December said they were absolutely sure or very likely to be vaccinated against Covid-19, an increase from September’s responses, according to the study.
Younger adults, women, blacks, people who live in suburbs or rural areas, and people with less education were more likely to say they didn’t want the vaccine. People on lower incomes and those with no health insurance were also more likely to say they weren’t planning on getting vaccinated, the researchers said.
A separate CDC study published February 1 found that most of the nearly 13 million people who were given at least one shot of a Covid-19 vaccine within the first month after the drugs were distributed were women of old age 50 years or older and likely not of Hispanic descent were white. Just over half of the cases were identified by race.
“More comprehensive reporting of racial and ethnic data at the provider and jurisdiction level is critical to ensure rapid detection and response to potential differences in COVID-19 vaccination,” the researchers said.